Aramark director credited dividend equivalent rights in Form 4
Aramark reported a routine insider equity update for a director.
Rhea-AI Filing Summary
Aramark reported a routine insider equity update for a director. On 12/17/2025, the reporting person received 96.688 shares of common stock as dividend equivalent rights tied to deferred stock units, at a stated price of $0 per share. These dividend equivalent rights vest on the same schedules as the underlying awards. After this transaction, the reporting person beneficially owned 30,513.088 shares of Aramark common stock in direct ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 96.688 shares
Grant/Award
1 txn
Insider
Heller Bridgette P
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 96.688 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 30,513.088 shares (Direct)
Footnotes (1)
- F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Aramark (ARMK) disclose in this Form 4?
Aramark disclosed that a director received 96.688 shares of common stock as dividend equivalent rights on 12/17/2025, related to deferred stock units.
What is the nature of the dividend equivalent rights reported for Aramark (ARMK)?
The filing states the dividend equivalent rights arose from Aramark's quarterly dividend and accrued on the director's deferred stock units, vesting on the same schedule as the underlying awards.
What is the relationship of the reporting person to Aramark (ARMK)?
The reporting person is identified as a Director of Aramark on the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.